![Synthesis of thiophene and N-substituted thieno[3,2-d] pyrimidine derivatives as potent antitumor and antibacterial agents Cover](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/6470763d71e4585e08a9dae7/cover-image.jpg)
References
- 1. H. N. Hafez and A. B. A. El-Gazzar, Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d] pyrimidines as new bioactive and pharmacological activities, Bioorg. Med. Chem. Lett.18 (2008) 5222–5227; DOI: 10.1016/j.bmcl.2008.08.071.
- 2. S. Abbas, M. Hussain, S. Ali, M. Parvez, A. Raza, A. Haider and J. Iqbal, Structural, enzyme inhibition, antibacterial and DNA protection studies of organotin(IV) derivatives of thiophene-2-carboxylic acid, J. Organomet. Chem. 724 (2013) 255–261; DOI: 10.1016/j.jorganchem.2012.11.033.
- 3. Y. Ni. A. Gopalsamy, D. Cole, Y. Hu, R. Denny, M. Lpek, J. Liu, J. Lee, J. P. Hall, M. Luong, J. B. Telliez and L. L. Lin, Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors, Bioorg. Med. Chem. Lett. 21 (2011) 5952–5956; DOI: 10.1016/j.bmcl.2011.07.069.
- 4. T. P. Heffron, M. Berry, G. Castanedo, C. Chang, I. Chuckowree, J. Dotson, A. Folkes, J. Gunzner, J. D. Lesnick, C. Lewis, S. Mathieu, J. Nonomiya, A. Olivero, J. Pang, D. Peterson, L. Salphati, D. Sampath, S. Sideris, D. P. Sutherlin, V. Tsui, N. C. Wan, S. Wang, S. Wong and B. Y. Zhu, Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor, Bioorg. Med. Chem. Lett.20 (2010) 2408–2411; DOI: 10.1016/j.bmcl.2010.03.046.
- 5. Q. Tan, Z. Zhang, J. Hui, Y. Zhao and L. Zhu, Synthesis and anticancer activities of thieno [3,2-d] pyrimidines as novel HDAC inhibitors, Bioorg. Med. Chem.22 (2014) 358–365; DOI: 10.1016/j.bmc.2013.11.021.
- 6. J. Kim, J. Kwon, D. Lee, S. Jo, O. Dongsik, C. Jihyun, E. Park, J. Y. Hwang, Y. Ko, I. Choi, M. K. Ju, J. Ahn, J. Kim, S.-J. Han, T.-H. Kim, J. Cechetto, J. Nam, S. Ahn, P. Sommer, M. Liuzzi and J. Lee, Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors, Bioorg. Med. Chem Lett. 24 (2014) 5473–5477; DOI: 10.1016/j.bmcl.2014.10.007.
- 7. K. W. Temburnikar, S. C. Zimmermann, N. T. Kim, C. R. Ross, C. Gelbmann, C. E. Salomon, G. M. Wilson, J. Balzarini and K. L. Seley-Radtke, Antiproliferative activities of halogenated thieno[3,2-d] pyrimidines, Bioorg. Med. Chem. 22 (2014) 2113–2122; DOI: 10.1016/j.bmc.2014.02.033.
- 8. A. J. Folkes, K. Ahmadi, W. K. Alderton, S. Alix, S. J. Baker, G. Box, I. S. Chuckowree, P. A. Clarke, P. Depledge, S. A. Eccles, L. S. Friedman, A. Hayes, T. C. Hancox, A. Kugendradas, L. Lensun, P. Moore, A. G. Olivero, J. Pang, S. Patel, G. H. Pergl-Wilson, F. I. Raynaud, A. Robson, N. Saghir, L. Salphati, S. Sohal, M. H. Ultsch, M. Valenti, H. J. A. Wallweber, N. C. Wan, C. Wiesmann, P. Workman, A. Zhyvoloup, M. J. Zvelebil and S. J. Shuttleworth, The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer, J. Med. Chem. 51 (2008) 5522–5532; DOI: 10.1021/jm800295d.
- 9. K. A. Chakraborti, B. Gopalakrishnan, M. E. Sobhia and M. Alpeshkumar, 3D-QSAR studies on thieno [3,2-d] pyrimidines as phosphodiesterase IV inhibitors, Bioorg. Med. Chem. Lett. 13 (2003) 1403–1408; DOI: 10.1016/S0960–894X(03)00172-0.
- 10. H. N. Hafez, H. A. R. Hussein and A. B. A. El-Gazzar, Synthesis of substituted thieno[2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents, Eur. J. Med. Chem. 45 (2010) 4026–4034; DOI: 10.1016/j.ejmech.2010.05.060.
- 11. H. N. Hafez, A. B. A. El-Gazzar and M. E. A. Zaki, Simple approach to thieno[3,2-d]-pyrimidines as new scaff olds of antimicrobial activities, Acta Pharm.66 (2016) 331–351; DOI: 10.1515/acph-2016-0029.
- 12. H. N. Hafez, A. B. A. El-Gazzar and G. A. M. Nawwar, Synthesis, biological and medicinal significance of S-glycosido-thieno[2,3-d]-pyrimidines as new anti-inflammatory and analgesic agents, Eur. J. Med. Chem. 45 (2010) 1485–1493; DOI: 10.1016/j.ejmech.2009.12.056.
- 13. H. N. Hafez and A. B. A. El-Gazzar, Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d] pyrimidines as new bioactive and pharmacological activity, Bioorg. Med. Chem. Lett. 18 (2008) 5222–5227; DOI: 10.1016/j.bmcl.2008.08.071.
- 14. Z. Liu, S. Wu, Y. Wang, R. Li, J. Wang, L. Wang, Y. Zhao and P. Gong, Design, synthesis and biological evaluation of novel thieno[3,2-d] pyrimidine derivatives possessing diaryl semicarbazone scaff olds as potent antitumor agents, Eur. J. Med. Chem. 87 (2014) 782–793; DOI: 10.1016/j.ejmech.2014.10.022.
- 15. M. E. Welker and G. R. Kulik, Synthesis of PI3K/Akt/mTOR signaling pathway inhibitors, Bioorg. Med. Chem.21 (2013) 4063–4091; DOI: 10.1016/j.bmc.2013.04.083.
- 16. E. Perspicace, V. Jouan-Hureaux, R. Ragno, F. Ballante, S. Sartini, C. La Motta, F. Da Settimo, B. Chen, G. Kirsch, S. Schneider, B. Faivre and S. Hesse, Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), Eur. J. Med. Chem. 63 (2013) 765–781; DOI: 10.1016/j.ejmech.2013.03.022.
- 17. T. R. Rheault, T. R. Caferro, S. H. Dickerson, K. H. Donaldson, M. D. Gaul, A. S. Goetz, R. J. Mullin, O. B. McDonald, K. G. Petrov, D. W. Rusnak, L. M. Shewchuk, G. M. Spehar, A. T. Truesdale, D. E. Vanderwall, E. R. Wood and D. E. Uehling, Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors, Bioorg. Med. Chem. Lett.19 (2009) 817–820; DOI: 10.1016/j.bmcl.2008.12.011.
- 18. G. C. Tron, T. Pirali, R. A. Billington, P. L. Canonico, G. Sorba and A. A. Genazzani, Click chemistry reactions in medicinal chemistry: Applications of the 1,3-dipolar cycloaddition between azides and alkynes, Med. Res. Rev.28 (2008) 278–308; DOI: 10.1002/med.20107.
- 19. J. A. Demaray, J. E. Thuener, M. N. Dawson and S. Sucheck, Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity, J. Bioorg. Med. Chem. Lett.18 (2008) 4868–4871; DOI: 10.1016/j.bmcl.2008.07.087.
- 20. J. Wu, N. Green, R. Hotchandani, Y. Hu, J. Condon, A. Huang, N. Kaila, H. Q. Li, S. Guler, W. Li, S. Y. Tam, Q. Wang, J. Pelker, S. Marusic, S. Hsu, J. P. Hall, J. B. Telliez, J. Cui and L. L. Lin, Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-a production in human whole blood, Bioorg. Med. Chem. Lett.19 (2009) 3485–3488; DOI: 10.1016/j.bmcl.2009.05.009.
- 21. C. Gill, G. Jadhav, M. Shaikh, R. Kale, A. Ghawalkar, D. Nagargoje and M. Shiradkar, Clubbed[1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis, Bioorg. Med. Chem. Lett.18 (2008) 6244–6247; DOI: 10.1016/j.bmcl.2008.09.096.
- 22. M. M. Kamel and N. Y. Megally Abdo, Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents, Eur. J. Med. Chem. 86 (2014) 75–80; DOI: 10.1016/j.ejmech.2014.08.047.
- 23. Y. P. Hou, J. Sun, Z. H. Pang, P. C. Lv, D. D. Li, L. Yan, H. J. Zhang, E. X. Zheng, J. Zhao and H. L. Zhu, Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors, Bioorg. Med. Chem.19 (2011) 5948–5954; DOI: 10.1016/j.bmc.2011.08.063.
- 24. H. Wamhoff, M. Ertas and S. M. S. Atta, Notizen heterocyclic β-enamino esters, 39. Synthesis of 1H-pyrazolo[3,4-d]pyrimidines, Liebigs Ann. Chem.9 (1985) 1910–1916; DOI: 10.1002/jlac.198519850918.
- 25. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anti-cancer drug screening, J. Natl. Cancer Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.
- 26. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and J. M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst. 83 (1991) 757–766; DOI: 10.1093/jnci/83.11.757.
- 27. M. J. Weinstein and G. H. Wagman, Plant-derived Antibiotics, in Antibiotics Isolation, Separation and Purification (Ed. L. A. Mitscher), Elsevier, Amsterdam 1978, p. 464.
- 28. H. Naeimi, Z. S. Nazifi, S. M. Amininezhad and M. Amouheidari, Synthesis, characterization and in vitro antimicrobial activity of some new Schiff bases and their complexes, J. Antibiot. 66 (2013) 687–689; DOI: 10.1038/ja.2013.73.
- 29. P. G. Baraldi, H. El-Kashef, A. Farghaly, P. Vanelle and F. Fruttarolo, Synthesis of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines and related heterocycles, Tetrahedron60 (2004) 5093–5104; DOI: 10.1016/j.tet.2004.04.010.